Arbuckle Stuart A 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2025-07-01$450.23/sh−37,243$16,767,916→ 63,368 total
Holdings
- 140(indirect: By 401(k))
Common Stock